Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
BDSX
KROS
Add up to 3 more stocks
BDSX
Biodesix, Inc.
-3.82%
$27.95-1.11Delayed quote: Oct 6, 2026, 10:50 AM EDT
Market Cap
$227.52M
52W Range
$5.26 - $31.97
KROS
Keros Therapeutics, Inc.
-2.03%
$11.29-0.23Delayed quote: Oct 6, 2026, 10:49 AM EDT
Market Cap
$223.78M
52W Range
$9.69 - $22.55
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 24.88 | 0.85 |
| P/S Ratio | 2.21 | 14.90 |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 82.5% | 94.7% |
| Operating Margin | -31.4% | 28.9% |
| Net Margin | -27.0% | -553.9% |
| ROE | -303.6% | -31.7% |
| ROA | -29.1% | -28.9% |
| ROIC | -25.7% | -36.5% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 2.85 | 21.96 |
| Quick Ratio | 2.85 | 21.96 |
| Debt/Equity | 7.85 | 0.06 |
| Interest Coverage | -3.60 | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.